Please assess the completion status of the following clinical trial:

Trial Title: The Role of Platelet Rich Plasma for Erectile Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* history of mild to moderate erectile dysfunction measured by IIEF~Exclusion Criteria:~* history or prostate cancer treatment (prostatectomy, radiation, brachytherapy)

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: SHAM_COMPARATOR): All arms will have phlebotomy (blood drawn). This group will receive saline injection only.
- Platelet rich plasma (Type: EXPERIMENTAL): All arms will have phlebotomy (blood drawn). This group will receive PRP injection only.

Based on this trial design, predict the completion outcome and termination type (if applicable).